Experimental pill may become ‘new standard’ for pancreatic cancer
Clinical trials of daraxonrasib, a new pancreatic cancer treatment, have showed positive results by helping some patients live almost twice as long as with standard chemotherapy. The FDA has permitted expanded access to the drug to patients who meet certain criteria. CNN’s Jacqueline Howard reports.
